News Archive

 PHF filed the DMF for Solifenacin succinate in the USA (DMF No. 025488).

 Solifenacin is a competitive muscarinic receptor antagonist. Muscarin ( more )

PHF has notifiied Heliofit, new oral food supplement in soft gel capsules, to protect from UV-A and UV-B rays from inside.

Heliofit contains a blend o ( more )

 PHF has launched Siliver cps, containing 280 mg of Silymarin, food supplement effective for liver protection. ( more )

 PHF submitted the US DMF for Quetiapine Fumarate on February 14th, 2011 (DMF No. 024443).

Quetiapine is an atypical antipsychotic approved for the t ( more )

 PHF filed the DMF for Olopatadine HCl in the USA (DMF No. 024408).

 Olopatadine hydrochloride is an antihistamine used to treat itching associa ( more )

 PHF filed the DMF for Imatinib Mesylate in the USA (DMF No. 024287).

 Imatinib is currently marketed by Novartis as Gleevec (USA) or ( more )

 PHF filed the DMF for Lubiprostone in the USA (DMF No. 024286).

Lubiprostone (CAS No. 136790-76-6) is a drug used in the treatment of chronic idiopa ( more )

We are proud to announce that the new website has been published! ( more )